SEC Form 4 · accession 0001209191-16-142357
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward M. Kaye M.D.
Officer — President, CEO & CMO · Director
Period of report
Sep 19, 2016
Accepted (ET)
Sep 21, 2016 · 9:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 19, 2016 | M | 13,000 | $8.28 | A | 89,983 | D | |
| Common StockF1 | Sep 19, 2016 | S | 13,000 | $50.00 | D | 76,983 | D | |
| Common StockF1 | Sep 19, 2016 | M | 947 | $5.40 | A | 77,930 | D | |
| Common StockF1 | Sep 19, 2016 | S | 947 | $50.00 | D | 76,983 | D | |
| Common StockF1 | Sep 19, 2016 | M | 10,405 | $5.40 | A | 87,388 | D | |
| Common StockF1 | Sep 19, 2016 | S | 10,405 | $50.00 | D | 76,983 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (right to buy)F1 | $13.90 | Sep 19, 2016 | M | 13,000 | D | Jun 20, 2012 | Jun 20, 2012 | Common Stock | 13,000 | 80,358 | D |
| Incentive Stock Options (right to buy)F1 | $5.40 | Sep 19, 2016 | M | 947 | D | Apr 24, 2013 | Apr 24, 2022 | Common Stock | 947 | 0 | D |
| Non-Qualified Stock Options (right to buy)F1 | $5.40 | Sep 19, 2016 | M | 10,405 | D | Apr 24, 2013 | Apr 24, 2022 | Common Stock | 10,405 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on March 16, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.